AR5-19041-01427
3 vaccinations
2 coded responses
29 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 020 / MA
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Pfizer-BioNTech
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-04-17
- 2021-07-17
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Malaise, Pain — Feeling: Good · Site: PainFree text: The evening of injection, marked local paint only, not a big deal. The day after injection, slight malaise only. By the evening of the day after injection cup pretty much back to normal.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Cognitive disorder, Echocardiogram abnormal, Emergency care, Mitral valve calcification, Ophthalmic migraine, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: 48h after Pfzr booster, ocular migraine followed by 10 minutes of inability to read for comprehension. Emergency for probable TIA. CTA, MRI negative. Echo showed only mitral ring calcification s/p mitralplasty 2004.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-09-28
-
2022-10-03
Callback requested for02:00PM ET
-
2022-10-03
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): The evening of injection, marked local paint only, not a big deal. The day after injection, slight malaise only. By the evening of the day after injection cup pretty much back to normal.
Release 12 — 12 months, dose 3
Symptoms: 48h after Pfzr booster, ocular migraine followed by 10 minutes of inability to read for comprehension. Emergency for probable TIA. CTA, MRI negative. Echo showed only mitral ring calcification s/p mitralplasty 2004.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cognitive disorder | · | · | ✓ |
| SD | Echocardiogram abnormal | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Mitral valve calcification | · | · | ✓ |
| SD | Ophthalmic migraine | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Malaise | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release